Honey is not a proven treatment for high blood pressure, and the clinical evidence on whether it helps or hurts is genuinely mixed. A recent meta-analysis found that each additional gram of daily honey was actually associated with a slight rise in systolic blood pressure, while a separate trial in people with diabetes showed the opposite, a meaningful drop after three months of supplementation. The gap between these findings matters, and understanding it can help you decide whether adding honey to your routine makes any sense for your blood pressure.
What Human Studies Actually Show
The most comprehensive dose-response analysis to date, pooling data from multiple systematic reviews and clinical trials, found a linear relationship between honey intake and systolic blood pressure that goes in the wrong direction for anyone hoping honey is a fix. Each gram of honey consumed was linked to a systolic increase of about 0.09 mmHg. That is a tiny number per gram, but at a daily dose of several tablespoons it starts to add up. The same analysis cautioned against long-term honey use because of potential adverse effects on blood pressure, triglycerides, liver enzymes, and inflammatory markers.1PubMed Central. Dosage exploration of the effects of honey and its derivatives on cardiometabolic outcomes: an overview of systematic reviews and GRADE-assessed updated meta-analysis
That is the headline finding, and it is sobering. But not every study points in the same direction. A trial of people with type 2 diabetic neuropathy who took honey at a dose of roughly half a gram per kilogram of body weight each day for three months saw their systolic blood pressure drop from about 133 to 125 mmHg and their diastolic pressure fall modestly as well.2PubMed Central. Effect of Three Months of Honey Supplementation on Heart Rate Variability and Baroreflex Sensitivity in Type 2 Diabetic Neuropathy Patients That is a clinically meaningful reduction, roughly comparable to what mild-to-moderate lifestyle changes can achieve. The catch: these were people with a specific metabolic condition, not healthy adults hoping to prevent hypertension.
A large observational study of adults over 40 found that women who consumed honey up to six times per week had about a quarter lower odds of prehypertension compared to women who almost never ate it. Men showed no such benefit at any frequency.3PubMed. Associations between honey consumption and prehypertension in adults aged 40 years and older The sex difference is striking and unexplained, and the association in women was modest enough that it fell short of standard statistical thresholds at higher intake levels. This is suggestive, not conclusive.
Taken together, the human data tell an uncomfortable story for anyone looking for a simple answer. The pooled dose-response data lean slightly negative on blood pressure, but specific populations with existing metabolic disruption may respond differently. The honest takeaway is that eating honey for the express purpose of lowering your blood pressure is not supported by strong evidence, and consuming it in large amounts could nudge your numbers in the wrong direction.
How Honey’s Polyphenols Affect Blood Vessels
If the clinical picture is messy, the basic science at least offers a plausible story for why honey could, in theory, help. Honey contains dozens of phenolic compounds, including quercetin, kaempferol, and caffeic acid phenethyl ester, that have been shown in laboratory and animal studies to relax blood vessel walls, reduce the tendency of blood to clot, and prevent the oxidation of LDL cholesterol. These are three mechanisms that matter for cardiovascular health in general and blood pressure regulation in particular.4PubMed Central. The potential role of honey and its polyphenols in preventing heart diseases: a review
Animal research fills in more of the picture. When spontaneously hypertensive rats (a breed that develops high blood pressure on its own) were given honey supplements, their blood pressure dropped and markers of oxidative stress in their kidneys improved. The same honey did nothing to blood pressure in rats with normal readings.5PubMed Central. Honey Supplementation in Spontaneously Hypertensive Rats Elicits Antihypertensive Effect via Amelioration of Renal Oxidative Stress A follow-up study confirmed that honey further reduced systolic pressure in diabetic hypertensive rats but again had no effect on normotensive animals.6PubMed Central. Differential responses to blood pressure and oxidative stress in streptozotocin-induced diabetic Wistar-Kyoto rats and spontaneously hypertensive rats: effects of antioxidant (honey) treatment
This pattern, where honey helps when something is already wrong but does little when things are normal, shows up repeatedly in the research. It suggests that honey’s antioxidant compounds may be most useful in situations of heightened oxidative stress, such as poorly controlled diabetes or metabolic syndrome. If your blood pressure is slightly elevated due to oxidative damage in the blood vessels and kidneys, honey’s polyphenols might chip away at that underlying problem. If your blood pressure is elevated for other reasons, or if you are otherwise healthy, the sugar content of honey may simply outweigh any antioxidant benefit.
Why the Type of Honey Matters More Than You Would Expect
Not all honey is created equal, and this turns out to be one of the most important variables in the research. The polyphenol content of honey varies enormously depending on the flowers the bees foraged. Manuka honey had the highest phenolic content among varieties tested in one comparison, roughly double or more that of acacia and wild carrot honeys.7PubMed Central. Evaluation of the Antioxidant Activity of Three Varieties of Honey from Different Botanical and Geographical Origins A study of Kashmir honeys found that total phenolic content ranged threefold across apple, cherry, saffron, and wild bush varieties.8LWT. A chemometric approach to evaluate the phenolic compounds, antioxidant activity and mineral content of different unifloral honey types from Kashmir, India
A systematic review and meta-analysis of honey’s effects on cardiometabolic risk factors found significant subgroup differences by floral source and processing method. Robinia honey, clover honey, and raw honey showed beneficial effects on fasting glucose and total cholesterol, while other varieties did not reach the same thresholds.9Nutrition Reviews. Effect of honey on cardiometabolic risk factors: a systematic review and meta-analysis Processing matters too: raw honey retains more of its bioactive compounds than heat-treated or ultrafiltered commercial products. If you are going to use honey with any health purpose in mind, the supermarket squeeze bottle that has been heavily processed is probably the least useful option.
Stingless bee honey, produced by tropical bee species rather than the common European honeybee, is an interesting case. In rats fed a diet designed to produce metabolic syndrome, supplementation with stingless bee honey from Southeast Asia reduced systolic blood pressure from about 132 to 106 mmHg and diastolic pressure from about 85 to 71 mmHg. Both reductions were large and statistically robust.10PubMed Central. The Beneficial Effects of Stingless Bee Honey from Heterotrigona itama against Metabolic Changes in Rats Fed with High-Carbohydrate and High-Fat Diet Stingless bee honey tends to be higher in certain antioxidants and lower in sugar content, which could explain the stronger results. It is not widely available outside tropical regions, but it is gaining popularity in Southeast Asia, Australia, and parts of Central and South America.
Replacing Sugar, Not Adding More
The most consistent finding across honey research is that honey performs better when it replaces another sweetener rather than being added on top of an existing diet. This is a critical distinction that gets lost in most popular coverage of the topic. If you swap honey for the sugar in your morning tea, the net effect on your calorie and carbohydrate intake is roughly neutral, and you gain the polyphenols. If you add a tablespoon of honey to a diet that already includes plenty of sugar, you are just adding more sugar.
A review of honey’s cardioprotective effects highlighted an illuminating finding from rat studies: despite honey containing about 30% fructose by weight, honey-fed rats had lower triglyceride levels than rats fed an equivalent amount of pure fructose. Lipid oxidation in the heart tissue was also lower in the honey group.11PubMed Central. Cardioprotective Effects of Honey and Its Constituent: An Evidence-Based Review of Laboratory Studies and Clinical Trials Something about honey’s matrix of additional compounds appears to buffer the metabolic effects of its sugar content. However, a controlled trial in humans comparing honey, sucrose, and high-fructose corn syrup at equal doses found that all three produced similar metabolic responses, with diastolic blood pressure dropping slightly across all treatments.12The Journal of Nutrition. Consumption of Honey, Sucrose, and High-Fructose Corn Syrup Produces Similar Metabolic Effects in Glucose-Tolerant and -Intolerant Individuals That finding is a reality check: when tested head to head in people, honey did not outperform plain sugar on blood pressure.
Where honey does appear to have a more consistent edge over other sweeteners is in broader metabolic markers. The meta-analysis mentioned earlier found that honey reduced fasting glucose, total cholesterol, LDL cholesterol, and triglycerides across pooled trials, with more pronounced benefits from raw and certain floral varieties.9Nutrition Reviews. Effect of honey on cardiometabolic risk factors: a systematic review and meta-analysis Since metabolic syndrome as a whole is a driver of hypertension, improving these downstream markers might indirectly benefit blood pressure over time, even if the direct effect on your blood pressure reading is negligible or slightly negative.
Practical Amounts and How to Think About Dosing
If you still want to incorporate honey into your diet with cardiovascular health in mind, the research points toward a narrow window. The dose-response analysis found that the most favorable effect on HbA1c (a marker of long-term blood sugar control) occurred at around 10 grams per day, which is roughly half a tablespoon. At 50 grams and above, that benefit vanished, and adverse effects on blood sugar, triglycerides, and blood pressure became more likely.1PubMed Central. Dosage exploration of the effects of honey and its derivatives on cardiometabolic outcomes: an overview of systematic reviews and GRADE-assessed updated meta-analysis The trial that showed blood pressure reductions in people with diabetic neuropathy used a considerably higher dose, about 0.5 grams per kilogram of body weight daily, which works out to roughly 35 grams for a 150-pound person.2PubMed Central. Effect of Three Months of Honey Supplementation on Heart Rate Variability and Baroreflex Sensitivity in Type 2 Diabetic Neuropathy Patients
These two findings are genuinely in tension. The safest interpretation is that small amounts of raw, polyphenol-rich honey used as a substitute for refined sugar in your existing diet are unlikely to do harm and might offer modest metabolic benefits. Larger therapeutic doses might help in the context of diabetes-related cardiovascular damage, but they also carry a greater risk of raising blood sugar and blood pressure in other contexts. If you have high blood pressure and are on medication, honey supplementation should be discussed with your doctor rather than attempted independently.
A few practical points are worth keeping in mind. Use honey in place of sugar you were already consuming, not as an addition. Choose raw, minimally processed honey from a single floral source if you can identify one. Darker honeys, such as buckwheat, manuka, or wildflower varieties, tend to have higher polyphenol levels. Avoid heating honey excessively, as high temperatures degrade some of its bioactive compounds. And keep your daily intake modest: half a tablespoon to a tablespoon is a reasonable range for someone interested in the metabolic benefits without the downsides of excess sugar.
The Adulteration Problem
One risk that has nothing to do with honey’s inherent properties is that the product you buy may not be real honey. Adulteration of commercial honey with corn syrup, rice syrup, or other cheap sweeteners is a widespread global problem. Adulterated honey can raise blood sugar, contribute to weight gain, elevate blood lipids, and increase blood pressure, precisely the opposite of what you are hoping to achieve.13PubMed Central. The Toxic Impact of Honey Adulteration: A Review If you are using honey for health purposes, sourcing matters. Buying from a local beekeeper, choosing honey with a traceable origin, or looking for third-party purity testing can reduce your risk of getting a product that is mostly corn syrup with honey flavoring.
Broader Metabolic Benefits That May Circle Back to Blood Pressure
Even if honey’s direct effect on blood pressure readings is ambiguous, its broader metabolic profile is worth understanding. A review of honey’s protective effects against metabolic syndrome found that honey intake reduces blood sugar levels, prevents excessive weight gain, and improves lipid metabolism by lowering total cholesterol, triglycerides, and LDL while raising HDL.14PubMed Central. A Review on the Protective Effects of Honey against Metabolic Syndrome Metabolic syndrome is a cluster of conditions, including high blood pressure, that often travel together. Improving three or four of those conditions may eventually ease the fifth, even without a dramatic direct effect on any single one.
A comprehensive review of 48 clinical trials involving over 3,600 subjects concluded that more beneficial effects of honey intake than negative effects were observed across cardiovascular and metabolic risk factors, with the strongest benefits appearing when honey replaced other sweeteners in the diet.15PubMed Central. A Comprehensive Review of the Effect of Honey on Human Health The number of well-designed trials remains small, and the studies that exist vary enormously in the type and dose of honey used, the populations studied, and the outcomes measured. The researchers themselves consistently note that the evidence, while promising, is not yet strong enough for clinical recommendations.
Other Bee Products and Blood Pressure
Honey gets the most attention, but other bee products have attracted research interest for blood pressure. Royal jelly, the substance bees produce to feed their queens, contains proteins that, when broken down, release peptides capable of inhibiting angiotensin-converting enzyme, the same enzyme targeted by a widely prescribed class of blood pressure medications. Lab studies have identified several of these peptides and measured their inhibitory strength, with some showing potency in the low micromolar range.16PubMed Central. In Silico and In Vitro Screening and Mechanisms of Angiotensin I-Converting Enzyme Inhibitory Peptides from Protein Hydrolysates of Royal Jelly Proteins from honeybee pupae have similarly been hydrolyzed and found to produce ACE-inhibiting peptides in the laboratory.17European Food Research and Technology. Purification and identification of peptides with high angiotensin-I converting enzyme (ACE) inhibitory activity from honeybee pupae (Apis mellifera) hydrolysates with in silico gastrointestinal digestion
These findings are strictly laboratory-stage. Demonstrating that a protein fragment inhibits an enzyme in a test tube is a long way from showing that eating royal jelly lowers blood pressure in a person. The peptides would need to survive digestion, reach the bloodstream in meaningful concentrations, and act on the right targets in the body. None of that has been confirmed in human trials. Still, the research hints that the broader ecology of bee products, not just honey, may contain bioactive compounds relevant to cardiovascular regulation. Whether any of them prove clinically useful remains an open question that is years from being answered.